SCARB1 and neoplasm: A significant reduction in tumor growth was noted in both cases (particularly with combination therapy with docetaxel or oxaliplatin) with the effects noted in terms of lowered tumor cell proliferation, and angiogenesis and cell survival, with the entry likely mediated via SR-B1.